Your browser doesn't support javascript.
loading
Safety Measures for Maintaining Low Endophthalmitis Rate after Intravitreal Anti-Vascular Endothelial Growth Factor Injection before and during the COVID-19 Pandemic.
Tanaka, Koji; Shimada, Hiroyuki; Mori, Ryusaburo; Kitagawa, Yorihisa; Onoe, Hajime; Tamura, Kazuki; Nakashizuka, Hiroyuki.
Afiliação
  • Tanaka K; Department of Ophthalmology, School of Medicine, Nihon University, 1-6 Surugadai, Kanda, Chiyodaku, Tokyo 101-8309, Japan.
  • Shimada H; Department of Ophthalmology, School of Medicine, Nihon University, 1-6 Surugadai, Kanda, Chiyodaku, Tokyo 101-8309, Japan.
  • Mori R; Department of Ophthalmology, School of Medicine, Nihon University, 1-6 Surugadai, Kanda, Chiyodaku, Tokyo 101-8309, Japan.
  • Kitagawa Y; Department of Ophthalmology, School of Medicine, Nihon University, 1-6 Surugadai, Kanda, Chiyodaku, Tokyo 101-8309, Japan.
  • Onoe H; Department of Ophthalmology, School of Medicine, Nihon University, 1-6 Surugadai, Kanda, Chiyodaku, Tokyo 101-8309, Japan.
  • Tamura K; Department of Ophthalmology, School of Medicine, Nihon University, 1-6 Surugadai, Kanda, Chiyodaku, Tokyo 101-8309, Japan.
  • Nakashizuka H; Department of Ophthalmology, School of Medicine, Nihon University, 1-6 Surugadai, Kanda, Chiyodaku, Tokyo 101-8309, Japan.
J Clin Med ; 11(3)2022 Feb 07.
Article em En | MEDLINE | ID: mdl-35160327

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: J Clin Med Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: J Clin Med Ano de publicação: 2022 Tipo de documento: Article